CTLA-4 is expressed on T cells after activation and shares homology wi
th the CD28 costimulatory receptor. In contrast to CD28, CTLA-4 is tho
ught to be a negative regulator of T cell activation. Cross-linking of
CTLA-4 during activation of peripheral T cells reduces IL-2 productio
n and arrests T cells in G1. Much less is known about the function of
CTLA-4 in differentiated T cells. We have investigated the expression
and function of CTLA-4 in established Th1 and Th2 clones and in bulk p
opulations of Th1 and Th2 cells freshly derived in vitro from TCR tran
sgenic splenocytes. We found that CTLA-4 was induced under similar con
ditions and with similar kinetics following activation of both Th1 and
Th2 clones, However, CTLA-4 expression was much higher in Th2 than Th
1 clones and lines. This was confirmed by how cytometry, confocal micr
oscopy, and Northern blot analysis. The ratio of surface to intracellu
lar expression of CTLA-4 and its rate of endocytosis were similar in T
h1 and Th2 clones, Inhibition of binding of CTLA-4 to its ligands usin
g soluble anti-CTLA-4 mAb during stimulation with Ag increased the pro
duction not only of IL-2 by Th1 clones, but also that of IL-3 and IFN-
gamma by Th1 clones and of IL-3, IL-4, IL-5, and IL-10 by Th2 clones.
In contrast, when anti-CTLA-4 was coimmobilized with anti-CDS and anti
-CD28 mAbs, a decrease in the production of multiple cytokines was obs
erved. We conclude that CTLA-4 can function to suppress the production
of cytokines produced by both Th1 and Th2 cells.